Media Partners

The Journal of Immunotherapy and Precision Oncology (JIPO) is a peer-reviewed open-access journal published quarterly since 2018. It is indexed in PubMed Central (PMC), Scopus, and Directory of Open Access Journals (DOAJ). JIPO aims to publish high-quality articles that appeal to a broad readership of healthcare professionals and scientists, especially those with an interest in immunotherapy and precision oncology. Topics in the Journal include studies of immune system function and biology, new therapeutic approaches to different malignancies, mechanisms of resistance, clinical assessment, prognostic or predictive markers, targeted therapy, and more. Please visit jipoonline.org to learn more and submit a manuscript.